Contrasting Olympus (OCPNY) and The Competition

Olympus (OTCMKTS:OCPNY – Get Free Report) is one of 511 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Olympus to related businesses based on the strength of its earnings, valuation, risk, dividends, profitability, institutional ownership and analyst recommendations.

Institutional and Insider Ownership

0.0% of Olympus shares are owned by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.9% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Olympus and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Olympus 13.80% 24.30% 9.30%
Olympus Competitors -190.60% -186.87% -21.75%

Dividends

Olympus pays an annual dividend of $0.08 per share and has a dividend yield of 0.4%. Olympus pays out 9.8% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.1% and pay out 40.7% of their earnings in the form of a dividend.

Valuation & Earnings

This table compares Olympus and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Olympus $7.74 billion $1.03 billion 21.95
Olympus Competitors $1.90 billion $136.81 million 5.74

Olympus has higher revenue and earnings than its peers. Olympus is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Analyst Ratings

This is a breakdown of recent ratings for Olympus and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Olympus 0 0 1 0 3.00
Olympus Competitors 4320 10605 18414 839 2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 26.24%. Given Olympus’ peers higher probable upside, analysts clearly believe Olympus has less favorable growth aspects than its peers.

Risk and Volatility

Olympus has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Olympus’ peers have a beta of 2.58, indicating that their average stock price is 158% more volatile than the S&P 500.

Summary

Olympus beats its peers on 9 of the 15 factors compared.

Olympus Company Profile

(Get Free Report)

Olympus Corporation is a Japan-based medical technology company focused on developing and supplying equipment and services for medical procedures. Its products include gastrointestinal endoscopes and related systems, surgical endoscopes, and endotherapy devices used in diagnosis and treatment. The company’s roots date to 1919, when it was established in Japan as Takachiho Seisakusho to produce microscopes. Over time, Olympus became known for optical products, but it has since exited its camera and scientific solutions businesses to concentrate on medical technology.

Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.